2023 Call for innovative health technologies for low-resource settings. Focusing on non-communicable diseases



Appropriate, affordable, effective, safe, and high-quality technologies are required to deliver the best possible care to the patient and improve the population’s well-being. However, low-resource settings often struggle to identify health technologies tailored to their needs. Moreover, despite the increasing burden of noncommunicable diseases (NCDs), many health systems are unprepared to address such a burden. Innovative technologies have the potential to improve health outcomes and quality of life or to offer a solution to an unmet need.

Therefore, WHO is pleased to announce the opening of the 2023 call for innovative health technologies for low-resource settings especially for the provision of services related to screening, diagnosis, treatment, monitoring, and overall management of NCDs.


What is the WHO Compendium of health technologies for low-resource settings? 

The objective of the WHO Compendium is to compile and showcase emerging innovative health technologies for low-resource settings. Since 2010, WHO periodically opens a call for submissions of innovative technologies and performs evidence-based assessments focused on the uptake of innovations in low-resource settings. The WHO Compendium presents manufacturer-reported information and the results of the WHO assessment of selected submissions.


Focusing on non-communicable diseases

Noncommunicable diseases key facts:

  • Noncommunicable diseases (NCDs) kill 41 million people each year, equivalent to 74% of all deaths globally.
  • Each year, 17 million people die from a NCD before age 70; 86% of these premature deaths occur in low- and middle-income countries.
  • Of all NCD deaths, 77% are in low- and middle-income countries.
  • Cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million including kidney disease deaths caused by diabetes).
  • These four groups of diseases account for over 80% of all premature NCD deaths.
  • Tobacco use, physical inactivity, the harmful use of alcohol, unhealthy diets, and air pollution all increase the risk of dying from an NCD.
  • Detection, screening, and treatment of NCDs, as well as palliative care, are key components of the response to NCDs.

The 2023 Call will focus for the first time on technologies to address NCDs and it is open to commercially available technologies and prototypes. The previous editions of the WHO Compendium focused on other topics such as technologies for the COVID-19 response in 2020 and for Ebola and other outbreaks in 2015.

Despite the focus on NCDs, this call will consider submissions of technologies related to other diseases and health conditions. 


Update for the technologies previously featured in the WHO Compendium

For the first time since the first edition in 2011, WHO will receive updates for health technologies included in the previous editions of the WHO Compendium. The update submission can include simple edits (e.g., current list price) or provide new evidence for re-assessment.


Guidelines for submission

  • All forms should be submitted electronically using the WHO online platform.
  • Three distinct submission forms are available: one for commercially available technologies, one for prototypes, and one for updates.
  • Please select the form that better suits your submission.
  • The form will request your name and email for registration. Once you register you will receive an email with your link to the form. Please do not share this link since it is unique to you.
  • The submission form is divided into the following sections: A) Contact details, C) Technology details, D) Clinical condition or health problem addressed, E) Technical specifications, F) Regulatory assessment, G) Health technology evidence assessment, H) Health technology management assessment, and I) Intellectual property and local production assessments. Each section has a distinct set of questions and documentation requirements necessary for the assessment. Therefore, the extensive questionnaire will allow us to conduct a thorough evaluation.
  • The more complete the submitted dossier the better ground for the WHO assessment. 
  • Only complete submissions will be reviewed. Full submissions should include information for all the assessments (A-I). When a question or requirement is not applicable to the technology kindly enter “Not Applicable”.
  • The electronic form times out after one hour of no activity. To prevent data loss save the form by pressing the “Previous”, “Next”, or “Resume later” buttons.
  • The electronic form has an option for resuming later making it possible to input the data over different sessions.
  • For any technical issues contact us at [email protected].



Some of the assessments (eg., Regulatory assessment) will require the submitter to provide evidence to back up their claims. All information shared with WHO will be confidential. All evaluators are required to sign a confidentiality undertaking. Therefore, we encourage the submitters to share published and unpublished documentation to support their submissions. The final publication will only display the technical details (exactly as submitted) and the results of each WHO assessment. Kindly refer to the previous versions of the Compendium for examples of the published technologies’ profiles.


Submit your innovative technology

Submit your application using the forms below. Please select the form that suits best your type of submission:



Inclusion in the Compendium does not constitute a warranty by WHO of the fitness of any technology or product for a particular purpose, as no rigorous review for safety, efficacy, quality, applicability, or cost acceptability was conducted by WHO. WHO will not be held to endorse nor recommend any technology or product included in the Compendium. WHO disclaims any and all liability whatsoever for any damage of any kind that may arise in connection with the procurement, distribution, and/or use of any such technology or product.


Leave a Reply

Your email address will not be published. Required fields are marked *